Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus - Wikidata - wikimedia - TriplyDB

Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus

Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus

http://www.wikidata.org/entity/Q28361123

about

Evaluation of quinolones in experimental animal models of infections.Successful single-dose prophylaxis of Staphylococcus aureus foreign body infections in guinea pigs by fleroxacin.Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital.Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance.In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.Mixed bacterial endocarditis in an intravenous drug misuser.Comparison of the effectiveness of various antibiotics in the treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis.

P2860

Q30446615-09A7C748-4225-46F1-926A-0CB0D084FBFB Q35245320-49A94151-935A-429A-BA05-9852DFE0CD55 Q35279768-492CEC44-C7E0-472A-B1D5-E4E2A9454FC2 Q35362532-C71ECD57-049A-49BD-8379-A037F37D0706 Q40633555-25C4739A-C32C-4EF3-9245-4950D391AE0B Q41813480-4DB1D396-9873-4638-87ED-1DDB8E91F3B5 Q43250858-FC3BAB7C-6D1A-4D7D-BF89-E1B5AB2C32BE Q44055508-3BF1DAD8-EBE1-4324-B892-36DA1301EBD8

P2860

Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus

http://www.wikidata.org/entity/Q28361123

description

1988 nî lūn-bûn

@nan

1988 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Ciprofloxacin therapy of exper ...... esistant Staphylococcus aureus

@ast

Ciprofloxacin therapy of exper ...... esistant Staphylococcus aureus

@en

Ciprofloxacin therapy of exper ...... esistant Staphylococcus aureus

@nl

type

label

Ciprofloxacin therapy of exper ...... esistant Staphylococcus aureus

@ast

Ciprofloxacin therapy of exper ...... esistant Staphylococcus aureus

@en

Ciprofloxacin therapy of exper ...... esistant Staphylococcus aureus

@nl

prefLabel

Ciprofloxacin therapy of exper ...... esistant Staphylococcus aureus

@ast

Ciprofloxacin therapy of exper ...... esistant Staphylococcus aureus

@en

Ciprofloxacin therapy of exper ...... esistant Staphylococcus aureus

@nl

P1433

Q28361123-97A0313D-493E-4A30-BA27-27F4F38165A1

P1476

Q28361123-A99C598E-5C30-4F92-9F05-E1CDA194A9F9

P2093

Q28361123-51802454-4360-4B60-9B86-1518153FF18E

Q28361123-5AA8F07A-76C1-431A-8951-5915FC924DEE

Q28361123-7AF326F5-34AE-4BF3-8AF0-97A5F8F5C59B

Q28361123-DA21075A-1054-4F26-9893-DC7C755FF58A

P2860

Q28361123-1D376217-43D8-4203-A283-2FC01658FEDE

Q28361123-410E35FA-9A3E-498F-8C3A-A32FC7E05571

Q28361123-49922DFA-1558-464B-803D-2143F874D8E2

Q28361123-4DC1B306-55E8-44FD-BF94-3B539A80B8D8

Q28361123-680D7F0B-240B-4F83-B87F-114BCD237498

Q28361123-763D79F3-C13A-4C15-A529-F474F8FA2881

Q28361123-7ACB9873-0DB8-4000-85BF-4601969920A1

Q28361123-841FDBC9-5BD6-48DD-95D3-F8A713719311

Q28361123-87C257FA-A12F-4074-9BE8-07AA89B2EDF4

Q28361123-8A52186E-C393-4B43-96C1-6F97BBB64ED6

P304

Q28361123-DD0C2345-4447-43AF-820E-E94C9BEF6583

P31

Q28361123-A388AB1C-0424-4184-898E-DEBF19F46D21

P356

Q28361123-70530AD2-A4CA-4438-8E32-0E04E25CA1C9

P407

Q28361123-3486E56E-B8C7-4441-ABDB-8954A8155091

P433

Q28361123-84750A5D-B118-4D02-9D65-114852688972

P478

Q28361123-7A9CC743-74AC-458C-A3C7-338AA842FFFD

P577

Q28361123-FD0E3ABF-86CB-413B-ACCD-6178FC75DB57

P698

Q28361123-D9F88978-C5A3-4612-A5F4-7B94ADA80E7B

P921

Q28361123-A60F61FE-0D2A-4386-B7A5-424B7CCE18CD

P932

Q28361123-7EB737FD-BE2E-47D1-8528-99C031D28464

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Ciprofloxacin therapy of exper ...... esistant Staphylococcus aureus

@en

P2093

M Fernandez-Guerrero

http://www.w3.org/2001/XMLSchema#string

M Rouse

http://www.w3.org/2001/XMLSchema#string

N Henry

http://www.w3.org/2001/XMLSchema#string

W Wilson

http://www.w3.org/2001/XMLSchema#string

P2860

Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study.

In vitro activity of ciprofloxacin (Bay o 9867)

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.

Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart

Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis.

Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus.

Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers.

Pharmacokinetics and tissue penetration of ciprofloxacin

In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.

Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.

P304

747-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.32.5.747

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

1988-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3164989

http://www.w3.org/2001/XMLSchema#string

P921

methicillin-resistant Staphylococcus aureus

P932

172264

http://www.w3.org/2001/XMLSchema#string